Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive "Pediatric" Type Protocol

被引:8
作者
Ganesan, Prasanth [1 ]
Sagar, Tenali Gnana [1 ]
Kannan, Krishnarathinam [1 ]
Radhakrishnan, Venkatraman [1 ]
Dhanushkodi, Manikandan [1 ]
Swaminathan, Rajaraman [3 ,4 ]
Sundersingh, Shirley [2 ]
Ganesan, Trivadi S. [1 ]
机构
[1] Canc Inst WIA, Dept Med Oncol, Madras, Tamil Nadu, India
[2] Canc Inst WIA, Dept Pathol, Madras, Tamil Nadu, India
[3] Canc Inst WIA, Dept Biostat, Madras, Tamil Nadu, India
[4] Canc Inst WIA, Tumor Registry, Madras, Tamil Nadu, India
关键词
Acute lymphoblastic leukemia; India; BFM protocol; Young adult; ADOLESCENTS; TRANSPLANTATION; TOXICITY; THERAPY; TRIAL;
D O I
10.1007/s12288-017-0892-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Young adults with acute lymphoblastic leukemia do better when treated on "pediatric" protocols. Young adults (18-30 years) with Ph-negative ALL treated between 2000 and 2014 were retrospectively analyzed. Two-hundred and thirty-two patients were included [median age 21 years (18-30); 176 (76%) males; median WBC 16,000/cmm]. Protocols used were: BFM 95 (N = 147, 63%), MCP-841 (N = 51, 22%), GMALL (N = 21, 9%), INCTR (N = 9, 4%) and UKALL (N = 4, 2%). Complete remission was achieved in 194/232 (84%). Twenty patients (9%) died due to toxicity which was higher with BFM versus others (18/147 vs. 2/85; p = 0.031). After a median follow-up of 48 months, median RFS and OS were 35.5 months (25-46), and 25 months (18-31) and actuarial RFS and OS (5-years) were 45% (37-53) and 39% (32-46). BFM protocol improved RFS (51 vs. 35%, p = 0.027) but not OS (43 vs. 33%, p = 0.2). The survival outcomes reported are 15-20% lower than those reported from West. Better supportive care and risk-adapted therapy may improve outcomes.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 18 条
[1]   Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment Protocol [J].
Arya, Laxman Singh ;
Kotikanyadanam, S. P. ;
Bhargava, Manorama ;
Saxena, Renu ;
Sazawal, Sudha ;
Bakhshi, Sameer ;
Khattar, Anshu ;
Kulkarni, Ketan P. ;
Adde, Melissa ;
Vats, Trib S. ;
Magrath, Ian .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (05) :370-375
[2]   How I treat acute lymphoblastic leukemia in older adolescents and young adults [J].
Curran, Emily ;
Stock, Wendy .
BLOOD, 2015, 125 (24) :3702-3710
[3]   Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia [J].
DeAngelo, D. J. ;
Stevenson, K. E. ;
Dahlberg, S. E. ;
Silverman, L. B. ;
Couban, S. ;
Supko, J. G. ;
Amrein, P. C. ;
Ballen, K. K. ;
Seftel, M. D. ;
Turner, A. R. ;
Leber, B. ;
Howson-Jan, K. ;
Kelly, K. ;
Cohen, S. ;
Matthews, J. H. ;
Savoie, L. ;
Wadleigh, M. ;
Sirulnik, L. A. ;
Galinsky, I. ;
Neuberg, D. S. ;
Sallan, S. E. ;
Stone, R. M. .
LEUKEMIA, 2015, 29 (03) :526-534
[4]   Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia [J].
Dhedin, Nathalie ;
Huynh, Anne ;
Maury, Sebastien ;
Tabrizi, Reza ;
Beldjord, Kheira ;
Asnafi, Vahid ;
Thomas, Xavier ;
Chevallier, Patrice ;
Nguyen, Stephanie ;
Coiteux, Valerie ;
Bourhis, Jean-Henri ;
Hichri, Yosr ;
Escoffre-Barbe, Martine ;
Reman, Oumedaly ;
Graux, Carlos ;
Chalandon, Yves ;
Blaise, Didier ;
Schanz, Urs ;
Lheritier, Veronique ;
Cahn, Jean-Yves ;
Dombret, Herve ;
Ifrah, Norbert .
BLOOD, 2015, 125 (16) :2486-2496
[5]   Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL) [J].
Goekbuget, Nicola ;
Beck, Joachim ;
Brandt, Kalina ;
Brueggemann, Monika ;
Burmeister, Thomas ;
Diedrich, Helmut ;
Faul, Christoph ;
Huettmann, Andreas ;
Kondakci, Mustafa ;
Kraemer, Doris M. ;
Ottmann, Oliver G. ;
Schwartz, Stefan ;
Serve, Hubert ;
Starck, Michael ;
Stelljes, Matthias ;
Stuhlmann, Reingard ;
Viardot, Andreas ;
Waesch, Ralph M. ;
Wendelin, Knut ;
Beelen, Dietrich ;
Arnold, Renate ;
Hoelzer, Dieter .
BLOOD, 2013, 122 (21)
[6]   Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL) [J].
Gökbuget, N ;
Hoelzer, D ;
Arnold, R ;
Böhme, A ;
Bartram, CR ;
Freund, M ;
Ganser, A ;
Kneba, M ;
Langer, W ;
Lipp, T ;
Ludwig, WD ;
Maschmeyer, G ;
Rieder, H ;
Thiel, E ;
Weiss, A ;
Messerer, D .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2000, 14 (06) :1307-+
[7]   Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group [J].
Hayakawa, F. ;
Sakura, T. ;
Yujiri, T. ;
Kondo, E. ;
Fujimaki, K. ;
Sasaki, O. ;
Miyatake, J. ;
Handa, H. ;
Ueda, Y. ;
Aoyama, Y. ;
Takada, S. ;
Tanaka, Y. ;
Usui, N. ;
Miyawaki, S. ;
Suenobu, S. ;
Horibe, K. ;
Kiyoi, H. ;
Ohnishi, K. ;
Miyazaki, Y. ;
Ohtake, S. ;
Kobayashi, Y. ;
Matsuo, K. ;
Naoe, T. .
BLOOD CANCER JOURNAL, 2014, 4 :e252-e252
[8]   Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003 [J].
Hough, Rachael ;
Rowntree, Clare ;
Goulden, Nick ;
Mitchell, Chris ;
Moorman, Anthony ;
Wade, Rachel ;
Vora, Ajay .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (03) :439-451
[9]   Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 [J].
Moericke, Anja ;
Reiter, Alfred ;
Zimmermann, Martin ;
Gadner, Helmut ;
Stanulla, Martin ;
Doerdelmann, Michael ;
Loening, Lutz ;
Beier, Rita ;
Ludwig, Wolf-Dieter ;
Ratei, Richard ;
Harbott, Jochen ;
Boos, Joachim ;
Mann, Georg ;
Niggli, Felix ;
Feldges, Andreas ;
Henze, Guenter ;
Welte, Karl ;
Beck, Joern-Dirk ;
Klingebiel, Thomas ;
Niemeyer, Charlotte ;
Zintl, Felix ;
Bode, Udo ;
Urban, Christian ;
Wehinger, Helmut ;
Niethammer, Dietrich ;
Riehm, Hansjoerg ;
Schrappe, Martin .
BLOOD, 2008, 111 (09) :4477-4489
[10]  
Mukhopadhyay D, 2007, J CLIN ONCOL, V25